QA: Blueprint Medicines Corp in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001597264_2023_Blueprint_Medicines_Corp.pdf

Logs

Graph

Absolute values for 0001597264, Blueprint Medicines Corp

  xvar xval
0 AssetsCurrent 1,046,651,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 33,344,000
3 remainder_Assets 269,907,000
4 LiabilitiesCurrent 183,234,000
5 LiabilitiesNoncurrent 116,714,000
6 remainder_Liabilities 535,277,000
7 CostOfGoodsAndServicesSold 17,813,000
8 SellingGeneralAndAdministrativeExpense 237,374,000
9 ResearchAndDevelopmentExpense 477,419,000
10 remainder_Expenses 14,184,000
11 remainder_Revenues 204,036,000
12 remainder_NetIncome -14,763,000
13 remainder_ComprehensiveNetIncome -6,310,000
  yvar yval
0 Assets 1,349,902,000
1 Liabilities 835,225,000
2 Expenses 746,790,000
3 Revenues 204,036,000
4 StockholdersEquity 514,677,000
5 NetIncome -557,517,000
6 ComprehensiveNetIncome -560,672,000
7 BaseVar 1,578,513,000
8 EconomicCapitalRatio 0.297

Edgar->Model Mapping

Feature Distribution

Change over Time